These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8600002)

  • 1. Leukaemic risk in polycythaemia vera and essential thrombocytopenia.
    Kwong YL
    Eur J Haematol; 1996; 56(1-2):90-2. PubMed ID: 8600002
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
    Krańik W
    Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroral 32P in polycythemia vera and essential thrombocytopenia. An old method still of current interest].
    Brandt L; Anderson H
    Lakartidningen; 1995 Aug; 92(34):2989-92. PubMed ID: 7650986
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 8. The choice of treatment in polycythaemia vera.
    Najean Y; Dresch C
    Drugs Exp Clin Res; 1986; 12(1-3):177-80. PubMed ID: 3525073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of polycythaemia vera and essential thrombocythaemia.
    Tefferi A; Silverstein MN
    Baillieres Clin Haematol; 1998 Dec; 11(4):769-85. PubMed ID: 10640216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.
    Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR
    N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history and management of polycythemia vera.
    Hoffman R; Wasserman LR
    Adv Intern Med; 1979; 24():255-85. PubMed ID: 371361
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute leukemia in polycythemia vera.
    Landaw SA
    Semin Hematol; 1986 Apr; 23(2):156-65. PubMed ID: 3704667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long remission in acute myeloblastic leukemia during Vaquez' polycythemia. Acute transformation of a myeloproliferative syndrome or successive neoplasms?].
    Dhermy D; Bernard JF; Renoux M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):814-7. PubMed ID: 214860
    [No Abstract]   [Full Text] [Related]  

  • 14. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
    Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
    Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and therapy of polycythaemia vera.
    Israëls MC
    Br J Haematol; 1969 Sep; 17(3):305. PubMed ID: 5257763
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical course and transformation of polycythemia vera and its relation to applied therapy].
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorús S
    Orv Hetil; 1987 Dec; 128(52):2723-30. PubMed ID: 3431872
    [No Abstract]   [Full Text] [Related]  

  • 17. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
    Boivin P
    Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Essential thrombocythemia: conventional therapy].
    Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
    Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32].
    Kraśnik W
    Pol Tyg Lek; 1975 Feb; 30(6):233-6. PubMed ID: 1054155
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
    Dingli D; Tefferi A
    Curr Hematol Malig Rep; 2006 Jun; 1(2):69-74. PubMed ID: 20425334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.